Yang Su
Impact in
-
- Heart Failure Treatment and Management
- Cardiovascular Function and Risk Factors
- Atrial Fibrillation Management and Outcomes
- Cardiac Arrhythmias and Treatments
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Heart Failure Treatment and Management 7
- Cardiovascular Function and Risk Factors 6
- Atrial Fibrillation Management and Outcomes 3
- Cardiac pacing and defibrillation studies 3
- Cardiac Arrhythmias and Treatments 2
- Cardiac electrophysiology and arrhythmias 2
- Co-authors
- Yawei Xu (10 shared papers)Dachun Xu (10 shared papers)Xianling Zhang (4 shared papers)Yuyan Lu (2 shared papers)Fenglei Zhang (5 shared papers)Sang‐Bing Ong (5 shared papers)Weijing Liu (2 shared papers)Jianhui Zhuang (1 shared paper)
- Journals
- Frontiers in Cardiovascular Medicine (4 papers)BMC Cardiovascular Disorders (3 papers)ESC Heart Failure (2 papers)Journal of Translational Medicine (2 papers)Cell Death Discovery (1 paper)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Yang Su
25 papers receiving 244 citations
Peers
Comparison fields: 5 of 66
- Cardiology and Cardiovascular Medicine 104
- Cancer Research 40
- Geriatrics and Gerontology 6
- Immunology 31
- Internal Medicine 5
Countries citing papers authored by Yang Su
This map shows the geographic impact of Yang Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang Su more than expected).
Fields of papers citing papers by Yang Su
This network shows the impact of papers produced by Yang Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang Su. The network helps show where Yang Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Yang Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 24 | |
| 2 | 2018 | 23 | |
| 3 | 2021 | 23 | |
| 4 | 2013 | 21 | |
| 5 | 2024 | 19 | |
| 6 | 2021 | 18 | |
| 7 | 2021 | 17 | |
| 8 | 2014 | 13 | |
| 9 | 2022 | 13 | |
| 10 | 2014 | 10 | |
| 11 | 2022 | 10 | |
| 12 | 2016 | 10 | |
| 13 | 2020 | 7 | |
| 14 | 2021 | 7 | |
| 15 | 2023 | 6 | |
| 16 | 2020 | 5 | |
| 17 | 2021 | 4 | |
| 18 | 2024 | 3 | |
| 19 | 2025 | 2 | |
| 20 | 2022 | 2 |
About Yang Su
Yang Su is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology, Oncology, Surgery and Epidemiology, having authored 30 papers that have together received 246 indexed citations. Recurring topics across this work include Heart Failure Treatment and Management (7 papers), Cardiovascular Function and Risk Factors (6 papers), Atrial Fibrillation Management and Outcomes (3 papers), Cardiac pacing and defibrillation studies (3 papers), Cytokine Signaling Pathways and Interactions (2 papers), Cardiac Arrhythmias and Treatments (2 papers), Cardiac electrophysiology and arrhythmias (2 papers) and Venous Thromboembolism Diagnosis and Management (2 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (104 citations), Cancer Research (40 citations), Geriatrics and Gerontology (6 citations), Immunology (31 citations) and Internal Medicine (5 citations). Yang Su has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Yawei Xu, Dachun Xu, Xianling Zhang, Yuyan Lu, Fenglei Zhang, Sang‐Bing Ong, Weijing Liu, Jianhui Zhuang, Zeyu Wang and Ke Wang. Their work appears in journals such as Frontiers in Cardiovascular Medicine, BMC Cardiovascular Disorders, ESC Heart Failure, Journal of Translational Medicine and Cell Death Discovery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.